These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 23046753
21. Challenges to macromolecular drug delivery. Juliano R. Biochem Soc Trans; 2007 Feb; 35(Pt 1):41-3. PubMed ID: 17233596 [Abstract] [Full Text] [Related]
22. Current status and future prospects of drug delivery systems. Jain KK. Methods Mol Biol; 2014 Feb; 1141():1-56. PubMed ID: 24567129 [Abstract] [Full Text] [Related]
23. Is the oral route possible for peptide and protein drug delivery? Morishita M, Peppas NA. Drug Discov Today; 2006 Oct; 11(19-20):905-10. PubMed ID: 16997140 [Abstract] [Full Text] [Related]
24. Recent Advances in Non-Invasive Delivery of Macromolecules using Nanoparticulate Carriers System. Shadab M, Haque S, Sheshala R, Meng LW, Meka VS, Ali J. Curr Pharm Des; 2017 Oct; 23(3):440-453. PubMed ID: 27784250 [Abstract] [Full Text] [Related]
25. Integrin targeted drug and gene delivery. Wang Z, Chui WK, Ho PC. Expert Opin Drug Deliv; 2010 Feb; 7(2):159-71. PubMed ID: 20095940 [Abstract] [Full Text] [Related]
27. Advances in the synthesis and application of nanoparticles for drug delivery. Park W, Na K. Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015 Feb; 7(4):494-508. PubMed ID: 25583540 [Abstract] [Full Text] [Related]
28. Transmucosal macromolecular drug delivery. Prego C, García M, Torres D, Alonso MJ. J Control Release; 2005 Jan 03; 101(1-3):151-62. PubMed ID: 15588901 [Abstract] [Full Text] [Related]
30. Targeting of nanoparticles: folate receptor. Kularatne SA, Low PS. Methods Mol Biol; 2010 Jan 03; 624():249-65. PubMed ID: 20217601 [Abstract] [Full Text] [Related]
31. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Deshayes S, Morris M, Heitz F, Divita G. Adv Drug Deliv Rev; 2008 Mar 01; 60(4-5):537-47. PubMed ID: 18037526 [Abstract] [Full Text] [Related]
32. Emerging strategies for the transdermal delivery of peptide and protein drugs. Schuetz YB, Naik A, Guy RH, Kalia YN. Expert Opin Drug Deliv; 2005 May 01; 2(3):533-48. PubMed ID: 16296773 [Abstract] [Full Text] [Related]
33. Permeation enhancers in the transmucosal delivery of macromolecules. Sharma S, Kulkarni J, Pawar AP. Pharmazie; 2006 Jun 01; 61(6):495-504. PubMed ID: 16826967 [Abstract] [Full Text] [Related]
34. Drug delivery to the CNS and polymeric nanoparticulate carriers. Costantino L. Future Med Chem; 2010 Nov 01; 2(11):1681-701. PubMed ID: 21428839 [Abstract] [Full Text] [Related]
36. The performance of nanocarriers for transmucosal drug delivery. Csaba N, Garcia-Fuentes M, Alonso MJ. Expert Opin Drug Deliv; 2006 Jul 01; 3(4):463-78. PubMed ID: 16822222 [Abstract] [Full Text] [Related]
37. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery. Mäe M, Langel U. Curr Opin Pharmacol; 2006 Oct 01; 6(5):509-14. PubMed ID: 16860608 [Abstract] [Full Text] [Related]
38. Nanoparticle therapeutics for prostate cancer treatment. Sanna V, Sechi M. Nanomedicine; 2012 Sep 01; 8 Suppl 1():S31-6. PubMed ID: 22640911 [Abstract] [Full Text] [Related]
39. Oral delivery of therapeutic proteins and peptides: a review on recent developments. Gupta S, Jain A, Chakraborty M, Sahni JK, Ali J, Dang S. Drug Deliv; 2013 Aug 01; 20(6):237-46. PubMed ID: 23869787 [Abstract] [Full Text] [Related]
40. Recent advances in nanocarrier-based mucosal delivery of biomolecules. Kammona O, Kiparissides C. J Control Release; 2012 Aug 10; 161(3):781-94. PubMed ID: 22659331 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]